Chief Financial Officer

Chief Medical Officer

Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee

Amylyx Pharmaceuticals announces pricing of $175 million underwritten public offering of common stock

Amylyx 17.5M share Spot Secondary priced at $10.00

Amylyx Pharmaceuticals Prices $175 Million Common Stock Offering

Director, Biostatistics

Amylyx is a clinical-stage pharmaceutical company focused on developing novel therapies for high unmet needs. They are seeking an experienced and motivated Director of Biostatistics to provide strategic leadership in clinical development plans and regulatory submissions, while mentoring statisticians and collaborating across functions.

Senior Vice President, Human Resources and Talent Acquisition

Head of Talent & HR Business Partnering

Associate Director, Biostatistics

Sign up with Google

Sign in with Google